Department of Medicine 5 – Haematology and Oncology

Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome (2023) Naschberger E, Fuchs M, Dickel N, Kunz M, Popp B, Anchang CG, Demmler R, et al. Journal article CAR T-cell therapy in autoimmune diseases (2023) Schett G, Mackensen A, Mougiakakos D Journal article, Review article Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023) Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al. Journal article, Letter Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience (2023) Enßle JC, Wolf S, Scheich S, Weber S, Kramer M, Ruhnke L, Schliemann C, et al. Journal article Early clinical trial unit tumor board: a real-world experience in a national cancer network (2023) Weiss L, Dorman K, Boukovala M, Schwinghammer F, Jordan P, Fey T, Hasselmann K, et al. Journal article Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma (2023) Zundler S, Vitali F, Kharboutli S, Völkl S, Polifka I, Mackensen A, Atreya R, et al. Journal article Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systems (2023) Hippe K, Kreft A, Reu-Hofer S, Rosenwald A, Ferrazzi F, Daniel C, Amann KU, et al. Journal article Reset of inflammatory priming of joint tissue and reduction of the severity of arthritis flares by bromodomain inhibition (2023) Friščić J, Reinwald C, Böttcher M, Houtman M, Euler M, Chen X, Walker KI, et al. Journal article Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 (2023) Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, et al. Journal article Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib (2023) Häselbarth L, Karow A, Mentz K, Böttcher M, Roche-Lancaster O, Krumbholz M, Jitschin R, et al. Journal article